GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Debt-to-Revenue

Nortem Biogroup (XPAR:MLBIO) Debt-to-Revenue : 0.75 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Nortem Biogroup's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €2.97 Mil. Nortem Biogroup's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €2.44 Mil. Nortem Biogroup's annualized Revenue for the quarter that ended in Dec. 2023 was €7.20 Mil. Nortem Biogroup's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.75.


Nortem Biogroup Debt-to-Revenue Historical Data

The historical data trend for Nortem Biogroup's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Debt-to-Revenue Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-Revenue
0.57 0.55 0.75

Nortem Biogroup Semi-Annual Data
Dec21 Dec22 Dec23
Debt-to-Revenue 0.57 0.55 0.75

Competitive Comparison of Nortem Biogroup's Debt-to-Revenue

For the Packaged Foods subindustry, Nortem Biogroup's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortem Biogroup's Debt-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Debt-to-Revenue falls into.



Nortem Biogroup Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Nortem Biogroup's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.974 + 2.439) / 7.198
=0.75

Nortem Biogroup's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.974 + 2.439) / 7.198
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Dec. 2023) Revenue data.


Nortem Biogroup Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup Headlines

No Headlines